GPT and metabolic dysfunction-associated steatotic liver disease: Briefly, NAFLD could aggravate liver inflammation in HBV-infected patients with persistent normal ALT (immune tolerant and inactive carrier phase), and NAFLD increased the burden of advanced fibrosis only in the immune tolerant phase.